The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Gnedovskaya E.V.
Research Center of Neurology
Zabitova M.R.
Research Center of Neurology
Kremneva E.I.
Research Center of Neurology
Shabalina A.A.
Research Center of Neurology
Makarova A.G.
Research Center of Neurology
Tzipushtanova M.M.
Research Center of Neurology
Filatov A.S.
Research Center of Neurology
Krotenkova M.V.
Research Center of Neurology
Clustering of diagnostic MRI signs of cerebral microangiopathy and its relationship with markers of inflammation and angiogenesis
Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(12‑2): 22‑31
Views: 7152
Downloaded: 199
To cite this article:
Dobrynina LA, Gnedovskaya EV, Zabitova MR, et al. . Clustering of diagnostic MRI signs of cerebral microangiopathy and its relationship with markers of inflammation and angiogenesis. S.S. Korsakov Journal of Neurology and Psychiatry.
2020;120(12‑2):22‑31. (In Russ.)
https://doi.org/10.17116/jnevro202012012222
To perform cluster analysis of MRI signs of cerebral microangiopathy (small vessel disease, SVD) and to clarify the relationship between the isolated groups and circulating markers of inflammation and angiogenesis.
The identification of groups of MRI signs (MRI types) using cluster hierarchical agglomerative analysis and iterative algorithm of k-means and assessment of their relationship with serum concentrations of tumor necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor-A (VEGF-A), hypoxia-inducible factor 1-α (HIF1-α) determined by ELISA were performed in 96 patients with SVD (STRIVE, 2013) (65 women, average age 60.91±6.57 years).
Cluster analysis of MRI signs identified two MRI types of SVD with Fazekas grade 3 of white matter hyperintensity (WMH). MRI type 1 (n=18; 6 women, mean age 59.1±6.8 years) and MRI type 2 (n=22, 15 f., mean age 63.5±6.2 years) did not differ by age, sex, severity of hypertension, presence of other risk factors. MRI type 1 had a statistically significantly more pronounced WMH in the periventricular regions, multiple lacunes and microbleeds, atrophy, severe cognitive impairment and gait disorders compared with MRI type 2. Its formation was associated with a decrease in VEGF-A level. MRI type 2 had the significantly more pronounced juxtacortical WMH, white matter lacunes, in the absence of microbleeds and atrophy, and less severe clinical manifestations compared with MRI type 1. Its formation was associated with an increase in TNF-α level.
Clustering of diagnostic MRI signs into MRI types of SVD with significant differences in the severity of clinical manifestations suggests the pathogenetic heterogeneity of age-related SVD. The relationship of MRI types with circulating markers of different mechanisms of vascular wall and brain damage indicates the dominant role of depletion of angiogenesis in the formation of MRI type 1 and increased inflammation in the formation of MRI type 2. Further studies are needed to clarify the criteria and diagnostic value of differentiation of MRI types of SVD, and also their mechanisms with the definition of pathogenetically justified prevention and treatment of various forms of SVD.
Keywords:
Authors:
Gnedovskaya E.V.
Research Center of Neurology
Zabitova M.R.
Research Center of Neurology
Kremneva E.I.
Research Center of Neurology
Shabalina A.A.
Research Center of Neurology
Makarova A.G.
Research Center of Neurology
Tzipushtanova M.M.
Research Center of Neurology
Filatov A.S.
Research Center of Neurology
Krotenkova M.V.
Research Center of Neurology
Received:
13.10.2020
Accepted:
14.10.2020
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.